PROS1 and neoplasm: The staining of virus structural protein, hexon, in the tumor specimens at days5 and 8 after i.t. injection showed the vast majority of cells in the LoVo tumors treated with AdML-TYML expressed high levels of hexon protein, while treatment with non-targeted virus, AdML-5WT, resulted in much fewer hexon-expressing cells.